Alex Goldberg

NASDAQ Decliners Watch List: Novavax, Inc. (NASDAQ:NVAX) and Melco Crown Entertainment Limited (NASDAQ:MPEL) Added to Equity Profile Report's NASDAQ Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/03/2014 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Novavax, Inc. (NASDAQ:NVAX) and Melco Crown Entertainment Limited (NASDAQ:MPEL).

Novavax, Inc. (NASDAQ:NVAX) a clinical-stage biopharmaceutical company that focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases is currently down (-9.64%) on 4,052,317 shares traded. Novavax, Inc. (NASDAQ:NVAX) is currently down (-11.38%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Novavax, Inc. (NASDAQ:NVAX)

Melco Crown Entertainment Limited (NASDAQ:MPEL) a company that through its subsidiaries, develops, owns, and operates casino gaming and entertainment resort facilities in Macau is currently down (-0.08%) on 3,679,119 shares traded. Melco Crown Entertainment Limited (NASDAQ:MPEL) is currently down (-11.17%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Melco Crown Entertainment Limited (NASDAQ:MPEL)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com